Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2016 by University of North Carolina, Chapel Hill
Sponsor:
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Michael Knowles, MD, University of North Carolina, Chapel Hill
ClinicalTrials.gov Identifier:
NCT00807482
First received: December 11, 2008
Last updated: September 6, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2017
  Estimated Primary Completion Date: April 2017 (Final data collection date for primary outcome measure)
Publications: